MENU
Go to the list of all blogs
Dem Sem's Avatar
published in Blogs
May 08, 2023

MDGL Stock Price Target: 21% Upside Expected

MDGL, the stock of Madrigal Pharmaceuticals, has been showing signs of a bullish pattern since March 14, 2023. A Broadening Bottom pattern has emerged, which is a bullish reversal pattern. This pattern indicates that the stock has been undergoing increased volatility, with wider price swings, but is ultimately trending upwards.

This pattern was confirmed on April 24, 2023, when the stock broke out of the pattern's resistance level. The breakout was accompanied by strong volume, indicating that there was significant buying pressure, which is a positive sign for investors.

The current confidence level to reach the target price of 369.58 USD is 90%. This means that there is a high likelihood that the stock will reach this level in the near future. The distance to the target price is currently 21%, which represents a significant upside potential.

Investors who want to capitalize on this bullish pattern can consider the breakout price of 307.08 USD as an entry point. This is the price level at which the stock broke out of the pattern's resistance level and is therefore considered a strong buy signal.

The target (exit) price of 369.58 USD represents a potential gain of 20.3% from the breakout price. This is a significant return on investment and represents a good opportunity for investors who are looking to enter the market.

The Broadening Bottom pattern that has emerged in MDGL is a bullish reversal pattern that indicates the stock is trending upwards. The breakout of the pattern's resistance level on April 24, 2023, accompanied by strong volume, confirms this bullish trend. The current confidence level to reach the target price of 369.58 USD is high, and the distance to the target price represents a significant upside potential. Investors who are looking to capitalize on this trend can consider the breakout price of 307.08 USD as an entry point and set a target (exit) price of 369.58 USD.

Related Ticker: MDGL

MDGL's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for MDGL turned positive on October 08, 2024. Looking at past instances where MDGL's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MDGL's RSI Oscillator exited the oversold zone, of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where MDGL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on October 28, 2024. You may want to consider a long position or call options on MDGL as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MDGL advanced for three days, in of 291 cases, the price rose further within the following month. The odds of a continued upward trend are .

MDGL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 50-day moving average for MDGL moved below the 200-day moving average on October 07, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MDGL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MDGL entered a downward trend on October 28, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MDGL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.373) is normal, around the industry mean (12.657). P/E Ratio (0.000) is within average values for comparable stocks, (111.595). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.971). MDGL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (285.714) is also within normal values, averaging (225.870).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (null:REGN), Moderna (null:MRNA), Incyte Corp (null:INCY), Sarepta Therapeutics (null:SRPT), Exelixis (null:EXEL), Arrowhead Pharmaceuticals (null:ARWR), Novavax (null:NVAX), BioCryst Pharmaceuticals (null:BCRX), Adaptive Biotechnologies Corp (null:ADPT), Nektar Therapeutics (null:NKTR).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.92B. The market cap for tickers in the group ranges from 151 to 531.34B. NONOF holds the highest valuation in this group at 531.34B. The lowest valued company is MYMX at 151.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 1%. For the same Industry, the average monthly price growth was 2%, and the average quarterly price growth was -6%. MNPR experienced the highest price growth at 240%, while BICTF experienced the biggest fall at -89%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was -47%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was -3%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 86
Price Growth Rating: 59
SMR Rating: 94
Profit Risk Rating: 92
Seasonality Score: 6 (-100 ... +100)
View a ticker or compare two or three
MDGL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
200 Barr Harbor Drive
Phone
+1 267 824-2827
Employees
276
Web
http://www.madrigalpharma.com
Ad is loading...
In July, Apple (NASDAQ: AAPL) made history as the first company to close regular-session trading with a market capitalization exceeding $3.5 trillion. Despite early session declines, Apple stock reached an all-time high of $229.40 and closed at $228.68.
Swing trading involves holding positions for several days to weeks to capture gains from market movements that unfold over a medium-term horizon. This strategy relies on technical analysis to identify potential entry and exit points, often supplemented by fundamental analysis to strengthen trade decisions.
The cleaning sector has exhibited a notable performance increase, experiencing a +4.71% rise over the past week. This performance surge reflects positive market sentiment and possibly increasing demand within the sector.
The immuno-oncology sector, comprising companies that develop advanced technologies for cancer treatment, has shown promising performance recently. This sector's innovation and critical role in advancing cancer treatments have led to a significant market response, reflected in a notable +8.04% increase in performance over the past week. Below is an analysis of the key players in this group—Corvus Pharmaceuticals (CRVS), AnaptysBio (ANAB), and iTeos Therapeutics (ITOS)—focusing on market capitalization, price movements, volume changes, and technical indicators.
U.S. stocks took a hit as tech shares dropped and the yen strengthened, leading to a 1,033-point drop in the Dow. With growing concerns over the Fed's rate policy, analysts now predict multiple rate cuts to address rising economic risks.
The technology sector remains a dynamic space for investors, with certain themes like portable devices showing substantial growth potential. Over the past week, the portable devices theme has seen an impressive performance with a +14.86% increase, highlighting the strength and resilience of companies operating within this sector. In this article, we will explore key metrics such as market capitalization, price trends, and volume growth, while also taking a closer look at the individual performances of companies within this theme, particularly focusing on Apple Inc. (AAPL), CEVA Inc. (CEVA), and Generac Holdings Inc. (GNRC).
The performance of companies in the fish-selling category has attracted significant attention recently, primarily due to the group's impressive +19.69% increase in performance over the past week. The 'fish' category, which includes companies that sell or produce fish, often overlaps with firms involved in poultry, frozen meat, and dairy products. Notable companies in this sector include Lifeway Foods, Inc. (LWAY), Sanderson Farms, Inc., and Hormel Foods Corp. (HRL). In this article, we will explore the market dynamics, price movements, and volume changes affecting this sector, with a focus on the group of tickers HRL, LWAY, BRFS, and PPC.
Two standout models are at the core of Tickeron's new bots (robots). Identifying and acting on price drops ("search for dips") and leveraging significant volatility spikes.
Tickeron has introduced advanced AI trading bots designed for day traders, utilizing Financial Learning Models (FLMs) and technical analysis to optimize strategies in high-volatility markets. These bots are engineered to capitalize on price surges and provide precise, short-term trading opportunities.
The railroads sector has recently demonstrated impressive performance, with a notable +19.69% increase in performance over the past week. This surge underlines the sector's critical role in freight and passenger transportation across North America, providing essential infrastructure for both national and international trade logistics. This article delves into the sector's key players, their market performance, and recent trends that are shaping the future of rail transport.
The uranium sector has been gaining notable attention recently, with a sharp uptick in performance. As of last week, uranium companies have seen a significant increase in performance by +10.69%. This surge brings renewed focus to uranium, a critical element used in nuclear power generation. With nuclear energy gaining traction as a cleaner alternative, companies engaged in uranium acquisition, exploration, and development are well-positioned to capitalize on this demand.
Amazon (AMZN) saw a $54B market cap increase this week, driven by a 2.74% stock price surge. Despite the short-term volatility indicated by breaking its upper Bollinger Band, the company's strong positioning in AI and cloud computing continues to attract investor interest.
The financial markets saw a mix of gains and declining volatility between September 23-27, with key indexes like SPY, QQQ, and DIA posting positive returns. Despite rising stocks, volatility measures dropped, reflecting reduced market uncertainty. This article explores market trends and highlights AI-driven trading robots designed to capitalize on opportunities while managing risk.
Tickeron's AI-powered Trend Trading bots are revolutionizing stock investing by integrating Financial Learning Models (FLMs) to help hedge fund managers and traders uncover undervalued stocks. These bots provide actionable signals, apply advanced risk management strategies, and support disciplined growth, empowering investors to navigate complex financial markets with ease.
The aluminum construction companies have experienced a significant boost, with the segment seeing a +11.13% increase in performance over the past week. This growth is largely driven by the rising demand for lightweight materials, particularly in the automotive sector, where aluminum is being widely adopted to improve fuel efficiency. The aluminum industry plays a vital role in the U.S. economy, generating approximately $71 billion annually in direct economic impact, according to The Aluminum Association.
Unlock the potential of AI-powered swing trading with robots designed to track dips in top S&P 500 stocks. Whether you're a beginner or experienced trader, these tools help manage up to $20k per position, balancing risk and reward with advanced algorithms and market insights. Discover how to maximize returns in volatile markets!
Discover Tickeron's new AI-driven trading bots designed for high-volatility markets and impulse price action. Leveraging Financial Learning Models (FLMs) and technical analysis, these bots optimize trades, offer a 70% win rate, and execute strategies for day traders focused on fast market moves.
The Diesel Companies segment has displayed a notable increase of +9.44% in performance over the past week. This uptick highlights a positive trend in the sector, encompassing companies involved in the manufacturing of diesel vehicles and the distribution of transportation fuels.